Last Updated on October 6, 2024 by The Health Master
USFDA approval
USFDA approval: In a significant milestone, Zydus Lifesciences has garnered the coveted final nod from the United States Food and Drug Administration (USFDA) for their groundbreaking Norelgestromin and Ethinyl Estradiol Transdermal System, boasting a precise dosage of 150 mcg/35 mcg per day.
Recognized as the USRLD equivalent to Ortho Evra Transdermal System, this cutting-edge pharmaceutical marvel promises to revolutionize the contraceptive landscape.
A Breakthrough Contraceptive Solution
Overview: The Norelgestromin and Ethinyl Estradiol Transdermal System, with its unique blend of hormone medication, stands as a formidable weapon in the battle against unintended pregnancies.
This marks the third hormonal transdermal patch greenlit by Zydus, showcasing their unwavering commitment to women’s reproductive health.
Manufacturing Prowess in Moraiya, Ahmedabad
Production Hub: The driving force behind this medical advancement is Zydus‘ state-of-the-art formulation manufacturing facility nestled in Moraiya, Ahmedabad.
This cutting-edge establishment is set to churn out the Norelgestromin and Ethinyl Estradiol Transdermal System, ensuring the highest quality standards.
A Look at the Market Impact
Market Insights: Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day, has already garnered significant attention in the pharmaceutical realm, with an impressive annual sales figure of $330 million in the US as of July 2023 (IQVIA MAT July 2023).
This stands as a testament to the enormous potential and demand for this groundbreaking contraceptive solution.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Breakthrough Pediatric HIV Treatment Receives Tentative USFDA Approval
USFDA Approval granted for Generic Sevelamer Carbonate Oral Suspension
USFDA approval granted for Generic Pirfenidone Capsules
USFDA Approval granted for Isotretinoin Capsules for Acne Treatment
USFDA approval issued for Mycophenolate Mofetil for Oral Suspension
USFDA issued EIR to Bajaj Healthcare: Gujarat
Johnson & Johnson under investigation for Pricing of TB Drug
Govt Job: For the post of Drug Inspector (19 posts)
Revised Schedule M: CDSCO organizes nationwide Workshops
A Pledge to Drug Safety: National Pharmacovigilance Week 2023
NABL issues vital Guidelines for Testing Laboratories
CDSCO’s Training Program for State Drug Regulators in Ranchi: Details
Phenylephrine used as a cold medicine is ineffective: USFDA Panel
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
